Clinically isolated syndrome: Diagnosis and risk of developing clinically definite multiple sclerosis

Autor: J. López-Gómez, B. Sacristán Enciso, M.A. Caro Miró, M.R. Querol Pascual

Publikováno v: Neurología (English Edition), Vol 38, Iss 9, Pp 663-670 (2023)

Introduction: In most cases, multiple sclerosis (MS) initially presents as clinically isolated syndrome (CIS). Differentiating CIS from other acute or subacute neurological diseases and estimating the risk of progression to clinically definite MS is

Externí odkaz: https://doaj.org/article/91b4fdeccf3f484e8ee89bdaf001fa4b

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial

Autor: Bar-Or, Amit, Montalban, Xavier, Hu, Xixi, Kropshofer, Harald, Kukkaro, Petra, Coello, Neva, Ludwig, Inga, Willi, Roman, Zalesak, Martin, Ramanathan, Krishnan, Kieseier, Bernd C., Häring, Dieter A., Bagger, Morten, Fox, Edward, Universitat Autònoma de Barcelona

Publikováno v: Scientia

Biomarker; Ofatumumab; Relapsing multiple sclerosis Biomarcador; Ofatumumab; Esclerosis múltiple recurrente Biomarcador; Ofatumumab; Esclerosi múltiple recurrent Introduction Several studies have described prognostic value of serum neurofilament li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80586cc727bc203517709ef89bedb5cb
https://ddd.uab.cat/record/275799

The potential of serum neurofilament as biomarker for multiple sclerosis

Autor: Eva Havrdova, Stefan Bittner, Jiwon Oh, Frauke Zipp, Mar Tintoré

Publikováno v: Brain
Scientia

Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients. Blood-based serum neurofilament light chain (sNfL) is currently under close investigation as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f989a94f437c402ca2a1ad55039f8fa
https://doi.org/10.1093/brain/awab241

Estudio de biomarcadores con utilidad clínica en neuropatías autoinmunes

Autor: Martín Aguilar, Lorena

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
TDX (Tesis Doctorals en Xarxa)
TDR. Tesis Doctorales en Red
instname

El dany axonal és el substrat patològic de la discapacitat permanent en molts trastorns neurològics, entre els quals es troben les neuropaties autoimmunes. Actualment no hi ha biomarcadors predictors de resposta terapèutica o de pronòstic a llar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09403bfb3df33ad5ab3d05a41c048ec1
https://ddd.uab.cat/record/251465

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Autor: Fissolo, Nicolás, Pignolet, Beatrice, Rio, Jordi, Vermersch, Patrick, Ruet, Aurélie, deSèze, Jerome, Labauge, Pierre, Vukusic, Sandra, Papeix, Caroline, Martinez-Almoyna, Laurent, Tourbah, Ayman, Clavelou, Pierre, Moreau, Thibault, Pelletier, Jean, Lebrun-Frenay, Christine, Bourre, Bertrand, Defer, Gilles, Montalban, Xavier, Brassat, David, Comabella, Manuel, Universitat Autònoma de Barcelona

Publikováno v: Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1003. ⟨10.1212/NXI.0000000000001003⟩
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3

ObjectivesThe study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab (NTZ)-treated patients with multiple sclerosis (MS) and to discr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7e556e5e596930706054f15c466294
https://doi.org/10.1212/nxi.0000000000001003